GLP-2 (Tirz) also known as Tirzepatide is a next-generation research peptide studied for its interaction with both GLP-1 and GIP receptor pathways within controlled laboratory environments. Its dual-pathway profile has made it a subject of interest in advanced peptide research focused on multi-receptor signaling and metabolic pathway analysis.
By engaging more than one receptor system, tirzepatide offers researchers a broader framework for studying peptide-receptor dynamics compared to single-pathway compounds. This makes it particularly relevant in experimental settings exploring complex biological interactions and signaling responses.
Phase 3 double-blind, randomized, controlled trial
https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide
Supplied as a lyophilized (freeze-dried) powder, GLP-2 (Tirz) is designed for stability, consistency, and precise handling in laboratory applications. Each batch is produced and handled under controlled conditions to maintain structural integrity across all vials.
